Litcius/Paper detail

Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention

Dominick J. Angiolillo, Usman Baber, Samantha Sartori, Carlo Briguori, George Dangas, David J. Cohen, Shamir R. Mehta, C. Michael Gibson, Rishi Chandiramani, Kurt Huber, Ran Kornowski, Giora Weisz, Vijay Kunadian, Keith G. Oldroyd, Yaling Han, Upendra Kaul, Bernhard Witzenbichler, Dariusz Dudek, Gennaro Sardella, Javier Escaned, Samin K. Sharma, Richard Shlofmitz, Timothy Collier, Stuart Pocock, Roxana Mehran

2020Journal of the American College of Cardiology87 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePercutaneous coronary interventionTicagrelorAspirinDiabetes mellitusInternal medicineCardiologyConventional PCIIntervention (counseling)ClopidogrelMyocardial infarctionEndocrinologyNursingAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchAtrial Fibrillation Management and Outcomes
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention | Litcius